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INTRODUCTION:  Desmoplastic  small  round  cell  tumor  is  a rare  malignancy  with  poor  prognosis  that  pre-
dominantly  affects  young  males.  Its  etiopathogenesis  is still unknown  and  diagnosis  can  be achieved  only
by  immunohistochemistry  and  cytogenetic  studies.  Due  to our  limited  knowledge  of the  pathologic  and
clinical nature  of  this  disease,  there  is  no  clear  consensus  regarding  the  optimal  therapeutic  procedures
for  treating  this  neoplasm.  A  high  degree  of  care  and  improvements  in diagnostic  capabilities  are  required
in  order  to  identify  this  entity  and avoid  misdiagnosis.
CASE PRESENTATION:  We  report a new  case  of a 29-year-old  male who  proceeded  to our  Emergency
Department  complaining  about  non-speciﬁc  abdominal  pain.  Physical  examination  revealed  no  abnor-
malities  except  for a  palpable  mass  in  the  lower  abdomen  and  a  diffuse  abdominal  pain.  Computed
Tomography  scan  showed  enlarged  paraortic  and  mesenteric  lymphadenopathy,  thickness  of  the small
bowel  wall  and  dispersed  masses  intraperitoneally.  He  underwent  an  exploratory  laparotomy  and  the
resultant  biopsy  revealed  desmoplastic  small  round  cell  tumor.
DISCUSSION:  Diagnosis  of desmoplastic  small  round  cell  tumor  can  easily  be  missed  because  it  presents
with  few  early  warning  symptoms  and signs,  while  the  routine  blood  tests  are  within  normal  limits.
CONCLUSION:  A  high  degree  of suspicion,  a thorough  physical  examination,  a full  imaging  check  and
an aggressive  therapeutic  approach  are  required  in order  to identify  this  disease  and  ﬁght  for  a  better
quality  of life  for these  patients.  In  addition  we make  a review  of  the  literature  in an  effort  to  clarify  the
epidemiological,  clinical  and  pathological  aspects  of this  entity.
ical A© 2011 Surg
. Introduction
Desmoplastic small round cell tumor (DSRCT) is a highly aggres-
ive and extremely rare malignant neoplasm with poor prognosis
hat was ﬁrst described by Sesterhenn et al. only two decades
go.1 It is considered a childhood cancer that predominantly
trikes male adolescents and young adults. This neoplasm primar-
ly occurs as multiple, widespread masses in the abdomen and
elvis without an apparent organ of origin and may  be accompa-
ied by extensive tumor implants throughout the peritoneum.2,3 It
s characterized by nests of small undifferentiated cells that show
mmunohistochemical evidence of epithelial, mesenchymal and
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neural differentiation. DSRCTs present a reciprocal chromosomal
translocation, t(11;22)(p13;q11 or q12), that results in the expres-
sion of a Ewing’s sarcoma and Wilm’s tumor-1 fusion gene with
chimeric message.4
Due to our limited knowledge on the pathologic and clinical
nature of this disease, there is no clear consensus regarding the
optimal therapeutic procedures for treating this neoplasm. More-
over, a high degree of care is required by the clinical physicians
and improvements in diagnostic capabilities in order to identify this
entity and avoid misdiagnosis. We  herein describe a new case of this
rare disease; a young male who  visited our hospital’s Emergency
Department complaining about vague abdominal symptoms.
2. Case presentation
2.1. Clinical history
Open access under CC BY-NC-ND license.A 29-year-old male from the Middle East living in Greece for
the last two years presented to our hospital’s Emergency Depart-
ment complaining about non-speciﬁc abdominal pain. He had
been in good health until two  months before, when he started
 BY-NC-ND license.
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nFig. 1. CT image of a large intraabdominal DSRCT: enlarged paraortic 
eeling exhausted, having anorexia, nausea, abdominal distension
nd pain. Physical examination revealed no abnormalities except
or a palpable mass in the lower abdomen and a diffuse abdomi-
al pain. The hemogram and the serum biochemistry were within
ormal limits. The inﬂammation markers (CRP, ferritin, ﬁbrinogen,
SR) and tumor markers (HCG, AFP, CEA, CA 19.9)5 were nor-
al, too. The tumor marker CA 125 was the only marker that was
levated by 5 times above the normal range. Abdominal ultrasonog-
aphy revealed enlargement of the right kidney, splenomegaly
nd free ﬂuid in the upper compartment of the abdomen. Com-
uterized Tomography (CT) scan showed enlarged paraortic and
esenteric lymphadenopathy (block), thickness of the small bowel
all and dispersed masses intraperitoneally (Fig. 1). The preoper-
tive diagnosis was lymphoma or tuberculosis of the small bowel.
e underwent an exploratory laparotomy and the resultant biopsy
evealed DSRCT.
During the post-operative period he presented recurrent ascites,
ypertension and mild post-operative pancreatitis (with increased
erum and urine amylase). CT scan of the pancreas and adrenal
lands as well as the serum cortisol and aldosterone levels were
ithin normal range. The tumor marker CA 125 returned to nor-
al  on the ﬁfth postoperative day. He underwent conservative
reatment with improvement of his general condition.
When he was stabilized he was referred to the Oncology
epartment of St. Savvas Hospital. He underwent chemo-radiation
herapy according to the P6 protocol. The latter consists of 7 courses
nvolving cyclophosphamide, doxorubicin, vincristine, ifosfamide
nd itoposide.2,6,7 Unfortunately, our patient received only three
ycles of chemotherapy because he decided to leave for his coun-
ry. Therefore he was lost to the follow-up and ever since all trace
f him has been lost. He was also planned to receive whole abdomi-
al radiotherapy (30 Gy). Radiation treatment started when he had
Fig. 2. The great omentumesenteric lymphadenopathy and dispersed masses intraperitoneally.
already undergone three cycles of chemotherapy but only one frac-
tion was given up to the time he decided to leave. Up to that time
all courses of treatment were well-tolerated and he was in good
general condition.
2.2. Surgical treatment
The exploratory laparotomy revealed ascites and an inﬁltration
of the whole great omentum from a malignant tumor, as well as
many secondary deposits to the abdominal wall and to the bowel.
The great omentum was resected (Fig. 2) and biopsies were taken
from all over the abdominal cavity.
2.3. Pathological ﬁndings
Our pathology department received the great omentum. It
measured 23 × 17 × 5.5 cm in size and had white or grey-white
areas of a hard-elastic consistency with a diameter of 2–7.5 cm.
Microscopically, these white or grey-white areas were composed
of sharply demarcated nests of varying size with small round
or oval cells, embedded in a desmoplastic stroma. Some tumor
cells had small hyperchromatic nuclei with inconspicuous nucle-
oli. In some areas the tumor cells formed cords surrounded by
desmoplastic stroma (Fig. 3). The immunohistochemical study
included: ABPAS, ABPAS D, vimentin, smooth muscle actin (SMA),
desmin, S-100 protein, neuron-speciﬁc enolase (NSE), antimelan-
otic antigen (HMB45), platelet endothelial cell adhesion molecule-1
(CD31), human hematopoietic progenitor cell antigen (CD34), Leu
M1 (CD15), synaptophysin, chromogranin, Leu-7 (CD57), MIC2
(CD99), Leucocyte common antigen (LCA), epithelial membrane
antigen (EMA), Carcinoembryonic antigen (CEA), cytokeratins
(CK7, CK19, CK20, CAM 5.2, a1-fetoprotein, P53, Ki 67, c-kit).8–11
 that was  resected.
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Fig. 3. Histological spectrum of DSRCT. (a) HE 20× desmoplastic stroma, medium size round cells, scant cytoplasm and indistinct borders, (b) HE 40× inconspicuous nucleoli.
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lig. 4. Immunoproﬁle of DSRCT. (a) DESMIN 20× strong cytoplasmic staining, (b) NS
he immunohistochemical results revealed positive to: vimentin,
esmin, NSE, CD15 (in a few cells), CD57, MIC2, EMA, CK7, CAM 5.2,
1AFP, P53 (in a few cells), Ki 67 (increased activity). (Fig. 4) The
istological ﬁndings were consistent with DSRCT.
. Discussion
DSRCT is a rare neoplasm, ﬁrstly recognized in 1987 by Ses-
erhenn et al. who described 17 cases of young males with
ndifferentiated malignant epithelial tumor arising in the pelvis or
crotum.1,6,12 Ever since only case reports or small series of patients
ave been announced, making diagnosis and management of this
isease a challenge for the physicians.
DSRCT shares characteristics with other small round cell
alignancies including Ewing’s Sarcoma, small cell Mesothe-
ioma, Neuroblastoma, Lymphoma, Primitive Neuroectodermal strong immunoreactivity, (c) EMA  40× EMA  diffuse membrane immunoreactivity.
tumor, Rhabdomyosarcoma and Wilm’s tumor. That is why the
DSRCT was until recently classiﬁed as a soft tissue undiffer-
entiated sarcoma.6,7,10,13 Pathology reveals clusters of small to
medium sized cells with hyperchromatic nuclei and increased
nuclear/cytoplasm ratio, surrounded by a dense desmoplas-
tic stroma.6 Immunohistochemical ﬁndings suggest a trilinear
coexpression including the epithelial marker keratin, the mes-
enchymal markers desmin and vimentin, and occasionally the
neuronal marker neuron-speciﬁc enolase (Primitive neuroecto-
dermal tumors/Ewing Sarcoma – PNET/ES – are desmin negative,
neuroblastoma is vimentin and desmin negative, small cell
mesothelioma is desmin, CD15, CD57 negative).8–11 Recent studies
have shown that DSRCTs present a reciprocal chromosomal translo-
cation, t(11;22)(p13;q11 or q12) that results in fusion of exon 7 of
the Ewing’s sarcoma gene EWS  on chromosome 22 with exon 8 of
the Wilms’ tumor suppressor gene WT1  on chromosome 11. The
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WS/WTI transcript is diagnostic of this tumor and codes for a pro-
ein that acts as a transcriptional activator that fails to suppress
umor growth.4,13,14
This extremely rare tumor chieﬂy affects males (96%) in their
econd or third decade of life. It behaves aggressively and only 29%
f patients survive up to 3 years.12 No ethnic predisposition or other
nown risk factors have been identiﬁed speciﬁc for the disease.
he neoplasm usually appears as an extensive intraabdominal or
ess often endopelvic mass with widespread peritoneal and lym-
hatic dissemination, without an apparent organ of origin. Other
reas less often affected may  include lymph nodes, the lining of
he abdomen, diaphragm, spleen, liver, lungs, testicles and ovaries.
he most common sites of metastatic spread are the liver, lungs
nd bones.
Despite the enormous size the tumors can grow to, there are few
arly warning signs. The majority of patients are young and healthy
s the tumor grows and spreads uninhibited within the abdomen
r pelvis. The most common presenting symptoms and signs of
ntraabdominal DSRCT include abdominal pain, distension, lack of
ppetite, a palpable abdominal mass, which are nonspeciﬁc and
ondiagnostic.7 The most common and useful imaging tool is the CT
can with intravenous and per os contrast. Although the CT scan is
ot diagnostic, the pattern of tumor distribution can be very suspi-
ious for DSRCT. Bulky, heterogeneous peritoneal soft tissue masses
ithout an apparent organ-based primary and mesenteric lym-
hadenopathy are characteristics of DSRCT. Diagnosis can only be
ade after removal of the suspicious mass and histological analysis
ith immunohistochemical demonstration of the trilinear nature
f the tumor.7,12 Fine needle aspiration cytology has also been used
or the diagnosis but still it’s not the most preferable way, since
olecular cytogenetics require larger biopsies.2,12
The ideal therapeutic strategy for treating this neoplasm is
till unclear due to the rarity of the tumor and consequently the
imited experience. Most reports suggest total resection of the
ass and postoperative multiagent chemotherapy and radiation
herapy as the best therapeutic options. Total resection is not
ften feasible because of the numerous peritoneal implants. Some
uthors suggest preoperative chemotherapy as a way  of shrinking
he widespread mass and reducing its vascularity. Intraperitoneal
yperthermic chemoperfusion has also been administered as an
ffort to reduce the bulk of the tumor. The experience with pseu-
omyxoma peritonei is behind this concept. Despite the combined
herapeutic approach, including surgery and chemoradiation ther-
py, the prognosis for these patients remains very poor, especially
or those with metastatic disease – 29% for a 3-year survival and
ust 18% for a 5-year survival.12,15
. Conclusion
A high degree of suspicion, a thorough physical examination,
 full imaging check and an aggressive therapeutic approach are
equired in order to identify this disease and ﬁght for a better qual-
ty of life for these young patients. The tumor marker CA 125 might
e a marker for the follow up of these patients, if it is elevated at
aseline. Future genetic therapies focused on developing targeted
mmunotherapy, might promise more optimistic results. Until then
ore than one medical specialities should collaborate in order to
ace the challenge and treat such patients.PEN  ACCESS
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